![Michael Solomon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Solomon
Direktor/Vorstandsmitglied bei
PROTARA THERAPEUTICS, INC.
Vermögen: 123 225 $ am 31.05.2026
Profil
Michael E.
Solomon was the founder of Epizyme, Inc. (2007) and served as Vice President-Discovery.
Current jobs include Independent Director at Protara Therapeutics, Inc. (2018) and Director at ValenzaBio, Inc. (2021).
Former jobs include Chief Executive Officer & Director at Ribometrix, Inc. (2017-2025), Director at ArTara Subsidiary, Inc., Principal at Millennium Pharmaceuticals, Inc., Chief Business Officer at Link Medicine Corp.
(2009-2012), Senior Associate at Banc of America Securities LLC, Venture Capital at SV Health Investors LLC (2016-2018), Chief Operating Officer at Ember Therapeutics, Inc. (2012-2015), Chief Operating Officer at Decibel Therapeutics, Inc. (2015-2016), and Vice President-Discovery at Hypnion, Inc. (2003-2007).
Education includes a doctorate from the University of Wisconsin and an undergraduate degree from the University of Massachusetts.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 26’500 ( 0.05% ) | 123 225 $ | 31.05.2026 |
Aktive Positionen von Michael Solomon
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2018 |
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Direktor/Vorstandsmitglied | 01.06.2021 |
Ehemalige bekannte Positionen von Michael Solomon
| Unternehmen | Position | Ende |
|---|---|---|
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease | Vorstandsvorsitzender | 09.01.2025 |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is an active manager. | Corporate Officer/Principal | 01.12.2018 |
| DECIBEL THERAPEUTICS, INC. | Geschäftsführer | 01.01.2016 |
Ember Therapeutics, Inc. /Old/
 Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Geschäftsführer | 01.01.2015 |
Link Medicine Corp.
 Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Develops disease modifying neurodegenerative therapies | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Michael Solomon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
25
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Hypnion, Inc.
 Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops neuroscience drugs | Commercial Services |
Link Medicine Corp.
Link Medicine Corp. Pharmaceuticals: MajorHealth Technology Develops disease modifying neurodegenerative therapies | Health Technology |
Banc of America Securities LLC
 Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is an active manager. | Finance |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides treatment for metabolic disorders and obesity diseases | Health Technology |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease | Health Technology |
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Protara Therapeutics, Inc.
 Protara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology Develops treatment options for patients with autoimmune and inflammatory diseases | Health Technology |
